Elite Pharmaceuticals, Inc. Proceeds from Sale of Other Assets
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Sale of Other Assets of -$600.00 thousand for the 3-month period ending 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2020-02-10
- Elite Pharmaceuticals, Inc. proceeds from sale of other assets for the quarter ending 2019-12-31 was -$600.00K.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 9 month |
|---|---|---|
| 2019-12-31 | -$600.00K 10-Q · filed 2020-02-10 | -$600.00K 10-Q · filed 2020-02-10 |